About
Biologics, Vaccines, Diagnostics, etc.
Areas of Focus
Categories
DiagnosticsBiologics & BiopharmaceuticalVaccineSmall Molecule PharmaceuticalSoutheastern U.S.
Team (19)
Adam Logal
Senior Vice President and Chief Financial Officer
Opko Health
executive
Alice Lin-Tsing Yu, M.D., Ph.D.
Opko Health
team_member
Arie Gutman
President of API
Opko Health
executive
Charles Bishop
Chief Executive Officer, OPKO Renal
Opko Health
executive
Craig Allen
Chief Executive Officer, BioReference Health
Opko Health
executive
Damien Burke
Chief Executive Officer, Eirgen Pharma
Opko Health
executive
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
950
By Status
UNKNOWN: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07145567Collaborator
Microangiopathy in Diabetes
N/ARecruiting
400 participants
Started: Mar 1, 2024 · Completed: Dec 31, 2027
NCT05433766Lead Sponsor
Patient-centred Smartphone AI for Protecting Vision in Macular Disease
N/AUnknown
500 participants
Started: Mar 8, 2023 · Completed: Apr 30, 2024
NCT05569226Lead Sponsor
OKKO Health Hyperacuity, Contrast and Colour Game Validation in Age-related Macular Degeneration
N/AUnknown
50 participants
Started: Nov 1, 2022 · Completed: Jun 1, 2023
Locations (1)
Headquarters
Miami, FL, United States
Map
Loading map...